3,0
5 feb 2017
Dipendente attuale, meno di un anno
Cambridge, East of England, England
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Great product and opportunity to help prevent morbidity and mortality of patients with CV disease. Company infrastructure us improving but a long way to go. Need better focus.
Svantaggi
Politics getting in the way of launch plans. Company hires people with expertise, and then Senior Managers who have no experience in the disease area but have longevity start to interfere and try and control the approach in the wrong way.